Alsaggaf, R. ., Pfeiffer, R. M., Pearce, E. E., Greene, M. H., Lochmuller, H. ., & Gadalla, S. M. (2024). Mortality Trends and Causes of Death in Myotonic Dystrophy Type 1 Patients From the UK Clinical Practice Research Datalink. Muscle Nerve. http://doi.org/10.1002/mus.28308
M. Greene
First name
M.
Middle name
H.
Last name
Greene
Wang, Y. ., Pfeiffer, R. M., Alsaggaf, R. ., Meeraus, W. ., Gage, J. C., Anderson, L. A., … Gadalla, S. M. (2018). Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink. Int J Cancer. http://doi.org/10.1002/ijc.31143
Alsaggaf, R. ., St George, D. M. M., Zhan, M. ., Pfeiffer, R. M., Wang, Y. ., Wagner, K. R., … Gadalla, S. M. (2018). Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity. JNCI Cancer Spectr. http://doi.org/10.1093/jncics/pky052
Alsaggaf, R. ., Pfeiffer, R. M., Wang, Y. ., St George, D. M. M., Zhan, M. ., Wagner, K. R., … Gadalla, S. M. (2019). Diabetes, Metformin, and Cancer Risk in Myotonic Dystrophy Type I. Int J Cancer. http://doi.org/10.1002/ijc.32801
Alsaggaf, R. ., St George, D. M. M., Zhan, M. ., Pfeiffer, R. M., Wang, Y. ., Anderson, L. A., … Gadalla, S. M. (2019). Benign tumors in myotonic dystrophy type I target disease-related cancer sites. Ann Clin Transl Neurol. http://doi.org/10.1002/acn3.50856